Slow down at these signs
An impressive label can leave gaps.
Keep the product, the person and the payment terms in view. Ask for details that can be checked outside the offer itself.
Check approval claims and research labels.
No medicine containing GHK-Cu had FDA (the U.S. Food and Drug Administration) approval as of September 30, 2026.
An NDC is a National Drug Code, a number in a government product directory.
FDA approval cannot be inferred from a product number in that directory; this rule was checked September 30, 2026.
Ask for the exact product and what the approval claim means. Keep the answer beside the skin-versus-injection distinction.
A research label is no care shortcut.
The words “research use only” do not decide whether the product is being sold for people to use as a drug. FDA looked at how sellers promoted their products in warning letters checked September 26, 2026.
Those letters made allegations about specific businesses; they were not court findings.
Do not treat a research label as the answer to a care question. Ask a licensed clinician about the concern you want addressed.
- Who is assessing my health concern?
- Who would prepare the product?
- Where can I check the clinician and pharmacy records?
- What human evidence supports this exact form?
Check the transaction as well as the claim.
Crypto is digital money.
A demand to pay only by wire, bank transfer, crypto, payment app or gift card is a scam signal, says FTC (the Federal Trade Commission) guidance checked September 26, 2026.
The warning is about being told these are the only ways to pay.
For an unclear quote, ask for included costs, later charges and exit terms in writing. You can pause while the missing details are explained.
The records behind these checks.
Use the FDA pages to read about product numbers and research labels. Use the FTC page to check payment demands.